Elucidating the secretion proteome of human embryonic stem cell-derived mesenchymal stem cells

Molecular and Cellular Proteomics

Volumn 6, Issue 10, 2007, Pages 1680-1689

  Sze, Siu Kwan ^a   de Kleijn, Dominique P V ^b,c   Lai, Ruenn Chai ^d   Tan, Eileen Khia Way ^b   Zhao, Hui ^d   Yeo, Keng Suan ^b   Low, Teck Yew ^b   Lian, Qizhou ^b   Lee, Chuen Neng ^e   Mitchell, Wayne ^b   El Oakley, Reida Menshawe ^e   Lim, Sai Kiang ^b,e,f  

^a NANYANG TECHNOLOGICAL UNIVERSITY   (Singapore)

^b GENOME INSTITUTE OF SINGAPORE   (Singapore)

^c UNIVERSITY MEDICAL CENTER UTRECHT   (Netherlands)

^d Nanyang Technological University   (Singapore)

^e NATIONAL UNIVERSITY OF SINGAPORE   (Singapore)

^f INSTITUTE OF MEDICAL BIOLOGY   (Singapore)

Author keywords

[No Author keywords available]

Indexed keywords

CYTOKINE ANTIBODY; GENE PRODUCT; JANUS KINASE; MAMMALIAN TARGET OF RAPAMYCIN; MITOGEN ACTIVATED PROTEIN KINASE; PROTEOME; STAT PROTEIN; TOLL LIKE RECEPTOR; TRANSFORMING GROWTH FACTOR BETA;

ARTICLE; BONE DEVELOPMENT; CARDIOVASCULAR SYSTEM; CONTROLLED STUDY; CULTURE MEDIUM; EMBRYO; EMBRYONIC STEM CELL; GENETIC TRANSCRIPTION; HEMATOPOIESIS; HUMAN; HUMAN CELL; MESENCHYMAL STEM CELL; METABOLISM; MICROARRAY ANALYSIS; PARACRINE SIGNALING; PREDICTION; PRIORITY JOURNAL; PROTEIN ANALYSIS; PROTEIN SECRETION; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; SIGNAL TRANSDUCTION; TISSUE DIFFERENTIATION; TISSUE REPAIR; VASCULARIZATION;

CHROMATOGRAPHY, LIQUID; CULTURE MEDIA, CONDITIONED; EMBRYONIC STEM CELLS; GENE EXPRESSION PROFILING; GENE EXPRESSION REGULATION; GENOME, HUMAN; HUMANS; MASS SPECTROMETRY; MESENCHYMAL STEM CELLS; METABOLIC NETWORKS AND PATHWAYS; PROTEIN ARRAY ANALYSIS; PROTEOME; REPRODUCIBILITY OF RESULTS; RNA, MESSENGER;

MAMMALIA;

EID: 35648974227     PISSN: 15359476     EISSN: None     Source Type: Journal    
DOI: 10.1074/mcp.M600393-MCP200     Document Type: Article

References (53)

1. Le Blanc, K., and Pittenger, M. (2005) Mesenchymall stem cells: progress toward promise. Cytotherapy 7, 36-45
2. Reiser, J., Zhang, X. Y., Hemenway, C. S., Mondal, D., Pradhan, L., and La Russa, V. F. (2005) Potential of mesenchymal stem cells in gene therapy approaches for inherited and acquired diseases. Expert Opin. Biol. Ther. 5, 1571-1584
3. Hui, J. H., Ouyang, H. W., Hutmacher, D. W., Goh, J. C., and Lee, E. H. (2005) Mesenchymal stem cells in musculoskeletal tissue engineering: a review of recent advances in National University of Singapore. Ann. Acad. Med. Singapore 34, 206-212
4. Caplan, A. I. (2005) Review: mesenchymal stem cells: cell-based reconstructive therapy in orthopedics. Tissue Eng. 11, 1198-1211
5. Menasche, P. (2005) The potential of embryonic stem cells to treat heart disease. Curr. Opin. Mol. Ther. 7, 293-299
6. Laflamme, M. A., and Murry, C. E. (2005) Regenerating the heart. Nat. Biotechnol. 23, 845-856
7. Kinnaird, T., Stabile, E., Burnett, M. S., and Epstein, S. E. (2004) Bone-marrow-derived cells for enhancing collateral development: mechanisms, animal data, and initial clinical experiences. Circ. Res. 95, 354-363
8. Caplan, A. I., and Dennis, J. E. (2006) Mesenchymal stem cells as trophic mediators. J. Cell. Biochem. 98, 1076-1084
9. Leedham, S. J., Brittan, M., McDonald, S. A., and Wright, N. A. (2005) Intestinal stem cells. J. Cell. Mol. Med. 9, 11-24
10. Togel, F., Hu, Z., Weiss, K., Isaac, J., Lange, C., and Westenfelder, C. (2005) Administered mesenchymal stem cells protect against ischemic acute renal failure through differentiation-independent mechanisms. Am. J. Physiol. 289, F31-F42
11. Patschan, D., Plotkin, M., and Goligorsky, M. S. (2006) Therapeutic use of stem and endothelial progenitor cells in acute renal injury: a̧ ira. Curr. Opin. Pharmacol. 6, 176-183
12. Miyahara, Y., Nagaya, N., Kataoka, M., Yanagawa, B., Tanaka, K., Hao, H., Ishino, K., Ishida, H., Shimizu, T., Kangawa, K., Sano, S., Okano, T., Kitamura, S., and Mori, H. (2006) Monolayered mesenchymal stem cells repair scarred myocardium after myocardial infarction. Nat. Med. 12, 459-465
13. Gnecchi, M., He, H., Noiseux, N., Liang, O. D., Zhaing, L., Morello, F., Mu, H., Melo, L. G., Pratt, R. E., Ingwall, J. S., and Dzau, V. J. (2006) Evidence supporting paracrine hypothesis for Akt-modified mesenchymal stem cell-mediated cardiac protection and functional improvement. FASEB J. 20, 661-669
14. Gnecchi, M., He, H., Liang, O. D., Melo, L. G., Morello, F., Mu, H., Noiseux, N., Zhang, L., Pratt, R. E., Ingwall, J. S., and Dzau, V. J. (2005) Paracrine action accounts for marked protection of ischemic heart by Akt-modified mesenchymal stem cells. Nat. Med. 11, 367-368
15. Mayer, H., Bertram, H., Lindenmaier, W., Korff, T., Weber, H., and Weich, H. (2005) Vascular endothelial growth factor (VEGF-A) expression in human mesenchymal stem cells: autocrine and paracrine role on osteoblastic and endothelial differentiation. J. Cell. Biochem. 95, 827-839
16. Nakagami, H., Maeda, K., Morishita, R., Iguchi, S., Nishikawa, T., Takami, Y., Kikuchi, Y., Saito, Y., Tamai, K., Ogihara, T., and Kaneda, Y. (2005) Novel autologous cell therapy in ischemic limb disease through growth factor secretion by cultured adipose tissue-derived stromall cells. Arterioscler. Thromb. Vasc. Biol. 25, 2542-2547
17. Van Overstraeten-Schlogel, N., Beguin, Y., and Gothot, A. (2006) Role of stromal-derived factor-1 in the hematopoietic-supporting activity of human mesenchymal stem cells. Eur. J. Haematol. 76, 488-493
18. + hematopoietic progenitor cells. J. Cell. Physiol. 184, 58-69
19. Liu, C. H., and Hwang, S. M. (2005) Cytokine interactions in mesenchymal stem cells from cord blood. Cytokine 32, 270-279
20. Washbum, M. P., Wolters, D., and Yates, J. R., III (2001) Large-scale analysis of the yeast proteome by multidimensional protein identification technology. Nat. Biotechnol. 19, 242-247
21. Lian, Q., Lye, E., Suan Yea, K., Khia Way Tan, E., Salto-Tellez, M., Liu, T. M., Palanisamy, N., El Oakley, R. M., Lee, E. H., Lim, B., and Lim, S. K. (2007) Derivation of clinically compliant MSCs from CD105+, CD24- differentiated human ESCs. Stem Cells 25, 425-436
22. Dominici, M., LeBlanc, K., Mueller, I., Slaper-Cortenbach, I., Marini, F., Krause, D., Deans, R., Keating, A., Prockop, D., and Horwitz, E. (2006) Minimal criteria for defining multipotent mesenchymal stromal cells. The International Society for Cellular Therapy position statement. Cytotherapy 8, 315-317
23. Tee, A. R., and Blenis, J. (2005) mTOR, translational control and human disease. Semin. Cell Dev. Biol. 16, 29-37
24. Gotherstrom, C., West, A., Liden, J., Uzunel, M., Lahesmaa, R., and Le Blanc, K. (2005) Difference in gene expression between human fetal liver and adult bone marrow mesenchymal stem cells. Haematologica 90, 1017-1026
25. Le Blanc, K. (2003) Immunomodulatory effects of fetal and adult mesenchymal stem cells. Cytotherapy 5, 486-489
26. Zhang, H., Fazel, S., Tian, H., Mickle, D. A., Weisel, R. D., Fujii, T., and Li, R. K. (2005) Increasing donor age adversely impacts beneficial effects of bone marrow but not smooth muscle myocardial cell therapy. Am. J. Physiol. 289, H2089-H2096
27. Kinnaird, T., Stabile, E., Burnett, M. S., Shou, M., Lee, C. W., Barr, S., Fuchs, S., and Epstein, S. E. (2004) Local delivery of marrow-derived stromal cells augments collateral perfusion through paracrine mechanisms. Circulation 109, 1543-1649
28. Haynesworth, S. E., Baber, M. A., and Caplan, A. I. (1996) Cytokine expression by human marrow-derived mesenchymal progenitor cells in vitro: effects of dexamethasone and IL-1α. J. Cell. Physiol. 166, 585-592
29. Barreau, C., Paillard, L., and Osborne, H. B. (2005) AU-rich elements and associated factors: are there unifying principles? Nucleic Acids Res. 33, 7138-7150
30. Espel, E. (2005) The role of the AU-rich elements of mRNAs in controlling translation. Semin. Cell Dev. Biol. 16, 59-67
31. Bhatia, R., and Hare, J. M. (2005) Mesenchymall stem cells: future source for reparative medicine. Congest. Heart Fail. 11, 87-93
32. Mauney, J. R., Volloch, V., and Kaplan, D. L. (2005) Role of adult mesenchymal stem cells in bone tissue engineering applications: current status and future prospects. Tissue Eng. 11, 787-802
33. Zimmet, J. M., and Hare, J. M. (2005) Emerging role for bone marrow derived mesenchymal stem cells in myocardial regenerative therapy. Basic Res. Cardiol. 100, 471-461
34. Lin, Z., Willers, C., Xu, J., and Zheng, M. H. (2006) The chondrocyte: biology and clinical application. Tissue Eng. 12, 1971-1984
35. Negoro, S., Kunisada, K., Tone, E., Funamoto, M., Oh, H., Kishimoto, T., and Yamauchi-Takihara, K. (2000) Activation of JAK/STAT pathway transduces cytoprotective signal in rat acute myocardial infarction. Cardiovasc Res. 47, 797-805
36. Ward, A. C., Touw, I., and Yoshimura, A. (2000) The Jak-Stat pathway in normal and perturbed hematopoiesis. Blood 95, 19-29
37. Ungureanu, D., and Slivennoinen, O. (2005) SLIM trims STATs: ubiquitin E3 ligases provide insights for specificity in the regulation of cytokine signaling. Sci. STKE 2005, pe49
38. Blair, H. C., Robinson, L. J., and Zaidi, M. (2005) Osteoclast signalling pathways. Biochem. Biophys. Res. Commun. 328, 728-738
39. Malemud, C. J. (2004) Protein kinases in chondrocyte signaling and osteoarthritis, Clin. Orthop. Relat. Res. Suppl. 427, S145-S151
40. Nigro, J., Osman, N., Dart, A. M., and Little, P. J. (2006) Insulin resistance and atherosclerosis. Endocr. Rev. 27, 242-259
41. Pandya, N., Santani, D., and Jain, S. (2005) Role of mitogen-activated protein (MAP) kinases in cardiovascular diseases. Cardiovasc. Drug Rev. 23, 247-254
42. Berenbaum, F. (2OG4) Signaling transduction: target in osteoarthritis. Curr. Opin. Rheumatol. 16, 616-622
43. Platanias, L. C. (2003) Map kinase signaling pathways and hematologic malignancies. Blood 101, 4667-4679
44. de Kleijn, D., and Pasterkamp, G. (2003) Toll-like receptors in cardiovascular diseases. Cardiovasc. Res. 60, 58-67
45. Ozato, K., Tsujimura, H., and Tamura, T. (2002) Toll-like receptor signaling and regulation of cytokine gene expression in the immune system. BioTechniques Suppl: 66-68, 70, 72 passim
46. Euler-Taimor, G., and Heger, J. (2006) The complex pattern of SMAD signaling in the cardiovascular system. Cardiovasc. Res. 69, 15-25
47. Bertolino, P., Deckers, M., Lebrin, F., and ten Dijke, P. (2005) Transforning growth factor-β signal transduction in angiogenesis and vascular disorders. Chest 128, 585S-590S
48. Bobik, A. (2006) Transforming growth factor-βs and vascular disorders. Arterioscler. Thromb. Vasc. Biol. 26, 1712-1720
49. Ruscetti, F. W., Akel, S., and Bartelmez, S. H. (2005) Autocrine transforming growth factor-β regulation of hematopoiesis: many outcomes that depend on the context. Oncogene 24, 5751-5763
50. Janssens, K., ten Dijke, P., Janssens, S., and Van Hul, W. (2005) Transforming growth factor-β1 to the bone. Endocr. Rev. 26, 743-774
51. Faler, B. J., Macsata, R. A., Plummer, D., Mishra, L., and Sidawy, A. N. (2006) Transforming growth factor-β and wound healing. Perspect Vasc. Surg. Endovasc. Ther. 18, 55-62
52. Wullschleger, S., Loewith, R., and Hall, M. N. (2006) TOR signaling in growth and metabolism. Cell 124, 471-484
53. Proud, C. G. (2004) Ras, PI3-kinase and mTOR signaling in cardiac hypertrophy. Cardiovasc. Res. 63, 403-413 Vol., No.